Skip to main content
Ikena Oncology, Inc. (IKNA)
NASDAQ: IKNA · IEX Real-Time Price · USD
1.300
-0.010 (-0.76%)
At close: Apr 26, 2024, 4:00 PM
1.280
-0.020 (-1.54%)
After-hours: Apr 26, 2024, 6:17 PM EDT

Ikena Oncology Revenue

In the year 2023, Ikena Oncology had annual revenue of $9.16M, a decrease of -41.35%. Revenue in the quarter ending December 31, 2023 was $659.00K, a -87.91% decrease year-over-year.

Revenue (ttm)
$9.16M
Revenue Growth
-41.35%
P/S Ratio
6.85
Revenue / Employee
$213,023
Employees
43
Market Cap
62.74M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20239.16M-6.46M-41.35%
Dec 31, 202215.62M-15.37M-49.59%
Dec 31, 202130.99M21.79M237.01%
Dec 31, 20209.19M-4.56M-33.15%
Dec 31, 201913.75M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Personalis 73.48M
Pro-Dex 48.24M
Equillium 36.08M
Cryo-Cell International 31.37M
Celularity 14.79M
Asensus Surgical 8.58M
Revenue Rankings

IKNA News

More News